Furthermore, in skin melanoma patients being treated with anti-CTLA4 mab (Ipilimumab), it was shown that the intratumoral immune cytolytic levels increased the infiltration of CD8+ T cells and the expression of MHC class I molecules [110]. Here, CTLA4 is linked to cutaneous melanoma.